Stephanie Fradette

Stephanie Fradette

Company: Biogen Idec

Job title: Senior Director - Medical & Clinical Development


Showcasing Clinical Findings for Toferson: Disease-Modifying Capabilities Targeting SOD1 Genetic Mutation 8:30 am

• Explaining ongoing clinical strategy in extended phase 3 clinical trials • Outlining lessons learnt regarding clinical endpoints from interactions with regulatory authorities • What is the future for therapies targeting familial ALS seeking approval?Read more

day: Day One AM

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.